Literature DB >> 12456778

Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses.

J R Batanian1, L R Cavalli, N M Aldosari, E Ma, C Sotelo-Avila, M B Ramos, J D Rone, C M Thorpe, B R Haddad.   

Abstract

Classic cytogenetic and comparative genomic hybridisation (CGH) data on osteosarcomas have been reported extensively in the literature. However, the number of paediatric osteosarcoma cases studied below the age of 14 years remains relatively small. This study reports four new cases of paediatric osteosarcoma in patients aged 3 to 13 years, evaluated by classic cytogenetics and CGH analyses. Clonal chromosomal alterations were detected in all the cases and included structural rearrangements at 1p11-13, 1q11, 4q27-33, 6p23-25, 6q16-25, 7p13-22, 7q11-36, 11p10-15, 11q23, 17p11.2-13, 21p11, and 21q11-22. The CGH analysis revealed recurrent gains at 1p, 4q, 17p, and 21q and losses at 3q and 16p. Five amplification sites were observed at 1q11-23, 6p21, 8q13, 8q21.3-24.2, and 17p. The data are discussed and compared with other cytogenetic reports in the literature.

Entities:  

Mesh:

Year:  2002        PMID: 12456778      PMCID: PMC1187277          DOI: 10.1136/mp.55.6.389

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  23 in total

1.  Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization.

Authors:  C Sakakura; T Mori; T Sakabe; Y Ariyama; T Shinomiya; K Date; A Hagiwara; T Yamaguchi; T Takahashi; Y Nakamura; T Abe; J Inazawa
Journal:  Genes Chromosomes Cancer       Date:  1999-04       Impact factor: 5.006

2.  DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma.

Authors:  M Tarkkanen; I Elomaa; C Blomqvist; A H Kivioja; P Kellokumpu-Lehtinen; T Böhling; J Valle; S Knuutila
Journal:  Int J Cancer       Date:  1999-04-20       Impact factor: 7.396

Review 3.  Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature.

Authors:  J A Bridge; M Nelson; E McComb; M H McGuire; H Rosenthal; G Vergara; G E Maale; S Spanier; J R Neff
Journal:  Cancer Genet Cytogenet       Date:  1997-05

4.  Comparative genomic hybridization analysis of adrenocortical tumors of childhood.

Authors:  B C Figueiredo; C A Stratakis; R Sandrini; L DeLacerda; M A Pianovsky; C Giatzakis; H M Young; B R Haddad
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

5.  Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization.

Authors:  K Persson; N Pandis; F Mertens; A Borg; B Baldetorp; D Killander; J Isola
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

6.  Cytogenetic evaluation of 20 primary breast carcinomas.

Authors:  L R Cavalli; L M Cavaliéri; L A Ribeiro; I J Cavalli; R Silveira; S R Rogatto
Journal:  Hereditas       Date:  1997       Impact factor: 3.271

7.  Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture.

Authors:  M Steinarsdóttir; I Pétursdóttir; S Snorradóttir; J E Eyfjörd; H M Ogmundsdóttir
Journal:  Genes Chromosomes Cancer       Date:  1995-08       Impact factor: 5.006

Review 8.  Osteosarcoma and other bone cancers.

Authors:  B P Himelstein
Journal:  Curr Opin Oncol       Date:  1998-07       Impact factor: 3.645

9.  Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas.

Authors:  A Forus; D O Weghuis; D Smeets; O Fodstad; O Myklebost; A Geurts van Kessel
Journal:  Genes Chromosomes Cancer       Date:  1995-09       Impact factor: 5.006

10.  Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization.

Authors:  M Tarkkanen; R Karhu; A Kallioniemi; I Elomaa; A H Kivioja; J Nevalainen; T Böhling; E Karaharju; E Hyytinen; S Knuutila
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

View more
  15 in total

1.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

2.  Identification and characterization of the human NOL7 gene promoter.

Authors:  Tanmayi P Mankame; Guolin Zhou; Mark W Lingen
Journal:  Gene       Date:  2010-03-03       Impact factor: 3.688

3.  Modeling familial cancer with induced pluripotent stem cells.

Authors:  Dung-Fang Lee; Jie Su; Huen Suk Kim; Betty Chang; Dmitri Papatsenko; Ruiying Zhao; Ye Yuan; Julian Gingold; Weiya Xia; Henia Darr; Razmik Mirzayans; Mien-Chie Hung; Christoph Schaniel; Ihor R Lemischka
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

4.  Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.

Authors:  Bekim Sadikovic; Paul Thorner; Susan Chilton-Macneill; Jeff W Martin; Nilva K Cervigne; Jeremy Squire; Maria Zielenska
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

5.  Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Authors:  Guolin Zhou; Colleen L Doçi; Mark W Lingen
Journal:  BMC Cell Biol       Date:  2010-09-27       Impact factor: 4.241

Review 6.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

7.  Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death.

Authors:  S Bhattacharya; A M Chalk; A J M Ng; T J Martin; A C Zannettino; L E Purton; J Lu; E K Baker; C R Walkley
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

8.  Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.

Authors:  Carl R Walkley; Rameez Qudsi; Vijay G Sankaran; Jennifer A Perry; Monica Gostissa; Sanford I Roth; Stephen J Rodda; Erin Snay; Patricia Dunning; Frederic H Fahey; Frederick W Alt; Andrew P McMahon; Stuart H Orkin
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

9.  Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma.

Authors:  Viviane Sonaglio; Ana C de Carvalho; Silvia R C Toledo; Carolina Salinas-Souza; André L Carvalho; Antonio S Petrilli; Beatriz de Camargo; André L Vettore
Journal:  Onco Targets Ther       Date:  2013-06-17       Impact factor: 4.147

10.  Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.

Authors:  Heidi M Namløs; Stine H Kresse; Christoph R Müller; Jørn Henriksen; Rita Holdhus; Gunnar Sæter; Oyvind S Bruland; Bodil Bjerkehagen; Vidar M Steen; Ola Myklebost
Journal:  Sarcoma       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.